Richard Skolier, who underwent an experimental cancer treatment, has died
Richard Skolier, a physician and researcher known for his scientific work in oncology and his involvement in an experimental cancer treatment developed based on his own research, has died in Australia at the age of 59. Three years ago, he was diagnosed with an aggressive brain tumor—glioblastoma. Skolier gained international recognition after agreeing to undergo an innovative therapy related to his own research in the treatment of melanoma.
Skolier, together with Professor Georgina Long, worked for many years on immunotherapy for patients with late-stage melanoma. Their research has significantly changed the prognosis for patients: whereas the chances of actual recovery used to be less than 10%, now about half of these patients can be cured.
After his own diagnosis, Skolier decided not to limit himself to standard treatment. In 2023, he became the first brain cancer patient to undergo combination immunotherapy prior to surgery. He also received a personalized vaccine tailored to the specific characteristics of his tumor.
The chances of a full recovery were very low, but doctors hoped to extend his life. Further tests showed signs of a positive immune response in the brain, and the results of his treatment sparked an early clinical trial in the U.S. Skolier openly said that he didn’t want to just wait for death after a diagnosis that, for most patients, means less than a year to live.
“I couldn’t wrap my head around just accepting inevitable death and not trying anything. Is it incurable cancer? To hell with that!” he told the BBC in 2024.
In an open letter announcing his death, Skolier wrote that even during the hardest times, he wanted to remain useful to science and to people.
“I wanted to continue making a contribution even in the darkest hour. I am writing this letter as a final farewell to everyone I had the immense privilege of loving, with whom I shared life’s adventures, worked alongside, and met throughout a life that can only be described as one filled with happiness, optimism, opportunity, and passion,” he wrote.
Skolier is survived by his wife, pathologist Katie Nicolle, and three children. In his farewell letter, he specifically thanked his family, who stood by him throughout his treatment.
“I write this knowing that my wonderful family has been by my side every minute, just as they have been throughout my entire journey with cancer. They are shining examples of the best in humanity and make me incredibly proud of them,” he wrote.
At the end of the letter, Skolier appealed to researchers and policymakers to continue investing in innovation.
“We can and must continue to push the boundaries to advance the field of cancer treatment,” he emphasized.
Source: BBC.
You might be interested in:
Chinese surgeons performed the first-ever ear-to-foot transplant on a patient following a workplace injury.
In the U.S., the first patient to receive a pig kidney transplant has died.
